Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Veryan Medical gains £5mm through its Series F venture round

Executive Summary

Veryan Medical Ltd. (vascular disease devices) has raised £5mm ($6.9mm) through its Series F venture round. Imperial Innovations co-led, and together with fellow returning backer Seroba Kernel, invested about half of the money. The company's chairman also participated. Imperial Innovations has invested £8.9mm to date and holds a 48.4% stake in Veryan. The company’s Series E round brought in £3.6mm last year.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies